For years, people struggling with their weight have heard the same advice: eat less, move more, try harder. If you’ve followed that advice and still found yourself regaining weight, you’re not alone. Many people assume they must be doing something wrong. But the conversation around obesity treatment is starting to shift.
The World Health Organization recently released its first-ever guidelines for treating obesity in adults, and the message reflects what obesity medicine specialists have been saying for years. Obesity is now recognized as a chronic, relapsing disease, not simply a lifestyle choice.
Clinically, obesity is often diagnosed using Body Mass Index, or BMI. A BMI of 30 or higher typically meets the diagnostic criteria of obesity. BMI is calculated by dividing weight in kilograms by height in meters squared. It isn’t a perfect measurement, but it remains a useful screening tool to estimate health risk.
So what do the new WHO guidelines recommend?
First, the WHO recommends long-term use of GLP-1 therapy for adults living with obesity, generally meaning treatment lasting six months or longer. Second, the guidelines emphasize intensive lifestyle intervention, including structured nutrition counseling, sustainable dietary changes, and regular physical activity.
That combination reflects what clinicians see every day. Weight regulation is influenced by many factors beyond willpower. Genetics affect how the body stores fat and regulates hunger. Neurobiology also plays a role, since the brain systems that control appetite and energy balance can function differently from person to person.
And then there’s real life. Long workdays, chronic stress, highly processed foods, and limited time for exercise all shape health behaviors. When these factors combine, maintaining weight loss can become incredibly difficult.
This is where modern medical treatment can help.
GLP-1 receptor agonists are FDA-approved medications originally developed to treat type 2 diabetes. Researchers later discovered they also support significant weight loss. These medications help regulate blood sugar, reduce appetite, and slow digestion, allowing people to feel full sooner and stay satisfied longer.
Over time, research has uncovered additional benefits. Studies suggest GLP-1 therapies may reduce cardiovascular risk, improve kidney health, and support chronic disease prevention. Evidence also shows improvements in blood pressure, LDL cholesterol, obstructive sleep apnea, chronic kidney disease, and fatty liver disease.
At 20/20 Lifestyles, our team provides a comprehensive medical weight loss program in Bellevue, WA that reflects this same approach. We combine physician-guided care, GLP-1 therapy when appropriate, and intensive lifestyle support through personalized coaching.
If you’ve been searching for obesity treatment or GLP-1 therapy in Bellevue, our team is here to help. Contact us to schedule a free consultation and learn whether this approach may be right for you.
This article was written by Dr. Padmini Nehru, Owner of PCN Medical PLLC and the 20/20 Lifestyles program. Dr. Nehru is dedicated to helping individuals improve their long-term health through personalized medical care, evidence-based lifestyle guidance, and a comprehensive approach to wellness.